Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2026-08-10 10:18:44 ET · period of report 2026-08-06 · accession 0001193125-26-341528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-10 10:18 | 2026-08-06 | HRTX | Hensley Mark Earl | COO | M - OptEx | — | +31.2K | 179.8K | +21% | — |
| D | 2026-08-10 10:18 | 2026-08-06 | HRTX | Hensley Mark Earl | COO | F - Tax | $0.5 | -8,888 | 170.9K | -5% | -$4,444 |
| D | 2026-08-10 10:18 | 2026-08-06 | HRTX | Hensley Mark Earl | COO | M - OptEx | $0.00 | -31.2K | 343.8K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-06 | M | A | 31,250 | — | 179,789 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Common | Common Stock | 2026-08-06 | F | D | 8,888 | $0.5 | 170,901 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-08-06 | M | D | 31,250 | $0.00 | 343,750 | D | $0.00 · — to — | 31,250 Common Stock | (F2) The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter. (F2) The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter. |